 |
|
|
|
|
The Apeiron team is committed to leveraging corporate communications both as a means to extend our reach on behalf of clients, and also as an important corporate development tool.
Our news and publication flow provides our network with regular updates on important events which Apeiron is either hosting, sponsoring or participating in, and is also intended to be a wide-ranging forum for professional exchange.
Your comments are welcomed and encouraged, and we look forward to seeing you at one of our events soon!
- Apeiron Advises Asahi Kasei Pharma
Corporation on $39 Million Financing, Sep, 2006
- Apeiron Seeking Dermatology Product Acquisitions
for Drug Development Company, Jul, 2006
- Apeiron Partners LLC announces
exclusive licensing agreement between Solstice Neurosciences, Inc. and DreamPharma
Corp., Jul 2006
- Apeiron Partners appoints Christopher U. Missling
as an additional
Managing Director, Mar 2006
- Apeiron Partners appoints Gustav Christensen
as an additional
Managing Director, Feb 2006
- BIO 2005: Getting From What We’re Selling to What They’re Buying,
Panel Discussion with Jeff Wager, June 2005
- CPP Advisors changes name to Apeiron Partners
LLC, June 2005
- Harvard
Business School Health Online Roundtable: CPP Advisors & Innovation
That Fits, June 2005
- Boston
Business Journal Article on CPP Advisors, January 2005
- MIT Corporate Venture Capital
Conference, September 2004
- Z-Cube press release announcing CPP Advisors,
September 2003
- Harvard Business School
Health Teleconference, July 2005
Publications
|
|
|
|
|
